Zota Health Care LImited — PPTs, 23-05-2026: Investor Presentation

Zota Health Care FY26 Highlights:

**Business Performance:** Zota delivered stellar performance, with consolidated revenue soaring 84% YoY to ₹538.66 Cr! 🚀 Davaindia segment was the growth engine, hitting ₹417.41 Cr. Importantly, the company turned profitable at the EBITDA level, reporting ₹25.98 Cr for FY26, a major turnaround from previous losses.

**Growth & Strategy:** Davaindia's rapid expansion is key, adding a record 997 new stores in FY26, taking total count to 2,579 (COCO/FOFO). Strategic stake increase in Everyday Herbal Group to 87.78% strengthens its OTC product portfolio and supply chain. The focus now shifts to optimizing existing stores for better profitability.

**Recent Developments:** Successfully completed a ₹350 Cr QIP. Welcomed M.S. Dhoni & Suniel Shetty as Davaindia brand ambassadors for wider reach. Further acquired Curexis and enhanced Everyday Herbal stake.

**Key Financials:** FY26 Revenue: ₹538.66 Cr (+84% YoY). FY26 EBITDA: ₹25.98 Cr. Davaindia Gross Merchandise Value (GMV): ₹457.06 Cr.

**Outlook:** Management plans to moderate Davaindia's expansion pace in the next two quarters to sharpen focus on profitability and store optimization. The long-term vision targets 5,000+ Davaindia stores by FY29 to deliver affordable healthcare across India. 🎯